Richard Marshak
Corporate Officer/Principal bei TRISALUS LIFE SCIENCES, INC.
Vermögen: 270 602 $ am 30.04.2024
Profil
Richard B.
Marshak is the founder of Nephraegis Therapeutics, Inc. (founded in 2018) where he holds the title of Director & Chief Business Officer.
He is currently working as Senior VP-Corporate Development & Strategy at TriSalus Life Sciences, Inc. since 2023.
Previously, Richard served as the Chief Executive Officer & Director at Mount TAM Biotechnologies, Inc. from 2016 to 2019.
He also worked at Abbott Laboratories as the General Manager-Alliance Management from 1999 to 2013.
Additionally, Richard was the President & Principal at LF Consulting from 2013 to 2022.
Dr. Marshak completed his undergraduate degree at the University of Pennsylvania and holds an MBA from The University of Chicago Booth School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.02.2024 | 27 251 ( 0,10% ) | 270 602 $ | 30.04.2024 |
Aktive Positionen von Richard Marshak
| Unternehmen | Position | Beginn |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Corporate Officer/Principal | 10.08.2023 |
Nephraegis Therapeutics, Inc.
 Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics, Inc. is a biopharmaceutical company that focuses on developing a family of proprietary drug candidates to prevent and treat acute kidney injury (AKI). The company is based in Lake Forest, IL. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The CEO of the company is Bryan F. Cox. | Gründer | 01.09.2018 |
Ehemalige bekannte Positionen von Richard Marshak
| Unternehmen | Position | Ende |
|---|---|---|
LF Consulting
 LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | Präsident | 01.06.2022 |
Mount TAM Biotechnologies, Inc.
 Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Vorstandsvorsitzender | 01.10.2019 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Richard Marshak
| University of Pennsylvania | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
LF Consulting
LF Consulting Miscellaneous Commercial ServicesCommercial Services LF Consulting specializes in data management and analysis. The private company is based in Sherwood, OR. The company's services include obtaining, transforming, processing, and visualizing data to help clients make informed decisions. | Commercial Services |
Nephraegis Therapeutics, Inc.
Nephraegis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nephraegis Therapeutics, Inc. is a biopharmaceutical company that focuses on developing a family of proprietary drug candidates to prevent and treat acute kidney injury (AKI). The company is based in Lake Forest, IL. The company's lead compound, NPH-022, is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties. The CEO of the company is Bryan F. Cox. | Health Technology |